DEXCOM INC Operating Income Loss

• DEXCOM INC showed an increase of +52.0% in Operating Income Loss from 2024 to 2025.
• This data is from DEXCOM INC's annual report (Form 10-K), filed with the SEC on February 12, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: -$11.27 million | Q3 2010: -$13.06 million | Q1 2011: -$11.87 million | Q2 2011: -$7.39 million | Q3 2011: -$13.31 million | Q1 2012: -$15.40 million | Q2 2012: -$14.70 million | Q3 2012: -$17.30 million | Q1 2013: -$10.90 million | Q2 2013: -$9.90 million | Q3 2013: -$5.80 million | Q1 2014: -$12.30 million | Q2 2014: -$5.80 million | Q3 2014: -$5.00 million | Q1 2015: -$12.70 million | Q2 2015: -$3.60 million | Q3 2015: -$42.40 million | Q1 2016: -$19.20 million | Q2 2016: -$20.10 million | Q3 2016: -$18.50 million | Q1 2017: -$40.40 million | Q2 2017: -$13.60 million | Q3 2017: -$500.0 thousand | Q1 2018: -$30.70 million | Q2 2018: -$4.90 million | Q3 2018: $13.90 million | Q1 2019: -$14.40 million | Q2 2019: -$800.0 thousand | Q3 2019: $56.00 million | Q1 2020: $33.60 million | Q2 2020: $67.80 million | Q3 2020: $94.10 million | Q1 2021: $45.90 million | Q2 2021: $101.00 million | Q3 2021: $118.30 million | Q1 2022: $41.30 million | Q2 2022: $77.00 million | Q3 2022: $147.50 million | Q1 2023: $47.20 million | Q2 2023: $128.10 million | Q3 2023: $205.50 million | Q1 2024: $101.10 million | Q2 2024: $158.00 million | Q3 2024: $152.00 million | Q1 2025: $133.70 million | Q2 2025: $212.60 million | Q3 2025: $242.50 million.
• Over the full 17 years of available data (2009 to 2025), DEXCOM INC's Operating Income Loss has grown by 2,089.4%.
• Historical annual values: Fiscal year 2025: $911.80 million | Fiscal year 2024: $600.00 million | Fiscal year 2023: $597.70 million | Fiscal year 2022: $391.20 million | Fiscal year 2021: $265.80 million | Fiscal year 2020: $299.50 million | Fiscal year 2019: $142.30 million | Fiscal year 2018: -$186.30 million | Fiscal year 2017: -$42.50 million | Fiscal year 2016: -$63.90 million | Fiscal year 2015: -$57.10 million | Fiscal year 2014: -$21.50 million | Fiscal year 2013: -$28.90 million | Fiscal year 2012: -$55.70 million | Fiscal year 2011: -$44.80 million | Fiscal year 2010: -$45.30 million | Fiscal year 2009: -$45.83 million.
• Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: August 8, 2026